Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patientsZahava Vadasz, Zev Sthoeger, Aharon Kessel et al.|The Journal of Allergy and Clinical Immunology In Practice|2017Cited by 54
Omalizumab therapy for chronic spontaneous urticaria: the Israeli experience.Menachem Rottem, Nancy Agmon‐Levin, Ramit Maoz‐Segal et al.|PubMed|2014Cited by 15
Adaptation and Validation of the Israeli Version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).Aharon Kessel, Elias Toubi, Yael Graif et al.|PubMed|2016Cited by 14